跳至主要内容
临床试验/NCT07321431
NCT07321431招募中不适用

The Optimal Measurement Time for the New Gallbladder Function Assessment Method: A Prospective, Multicenter, Double-Blind, Crossover Trial

Hepatopancreatobiliary Surgery Institute of Gansu Province5 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2026年1月7日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
120
试验地点
5
主要终点
Gallbladder Volume

研究概览

简要总结

This is a multicenter, prospective, randomized, double-blind, crossover study involving healthy individuals, aiming to evaluate the stability of oral protein bars + olive oil as a new method for determining gallbladder contraction function and its optimal diagnostic time window.

详细描述

This is a multicenter, prospective, randomized, single-blind, crossover study involving healthy individuals. This study will use a crossover trial method to compare oral fried eggs with oral protein bars + olive oil. Gallbladder ultrasound examinations will be performed at different time points to measure gallbladder volume, and the changes in gallbladder contraction rates at different time points under the two interventions will be calculated to determine the optimal time window for assessing gallbladder contraction function. On the other hand, the investigators will verify the stability of oral protein bars plus olive oil as a new method for measuring gallbladder contraction function, evaluate its reliability and reproducibility across different regions, hospitals, and populations, ensure its wide clinical application, and provide stronger support for the diagnosis and treatment of gallbladder-related diseases.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Diagnostic
盲法
Double (Investigator, Outcomes Assessor)

盲法说明

The PI, study biostatistician will be masked until database lock.

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者
是

入选标准

  • •Ultrasound assessment identifies people with normal biliary tract structure.

排除标准

  • •History of Endoscopic Retrograde Cholangiopancreatography
  • •Previous gallstone removal surgery with gallbladder preservation
  • •Other biliary tract diseases and related surgical history
  • •History of acute or chronic pancreatitis
  • •History of gastrointestinal surgery
  • •Gastrointestinal obstruction
  • •Dysfunction of the sphincter of Oddi
  • •Gallbladder neck polyps
  • •Abnormal gallbladder structure
  • •Gallbladder mass
  • •Biliary infection or stones
  • •Congenital biliary abnormalities
  • •Biliary injury or surgery
  • •Biliary tumors
  • •Gastrointestinal bleeding, liver cirrhosis, or other malignant diseases
  • •Significant arrhythmia, bradycardia, or atrioventricular block
  • •Severe hypertension, liver or kidney insufficiency
  • •Immune, endocrine, hematological, or mental disorders
  • •Severe cerebrovascular disease
  • •Allergy to relevant foods
  • •Pregnant or breastfeeding women
  • •Unwillingness or inability to consent to participation

研究组 & 干预措施

fried eggs

Experimental

First, the intervention of oral administration of 2 fried eggs is carried out. The size of the gallbladder is evaluated by ultrasound examination. The washout period is 1 week. After that, the first intervention process of group B is repeated.

干预措施: oral administration of 2 fried eggs (Dietary Supplement)

protein bars

Active Comparator

First, an intervention with oral protein bars + 50ml olive oil is conducted. The size of the gallbladder is evaluated through ultrasound examination. The washout period is 1 week. After that, the first intervention process of Group A is repeated.

干预措施: oral protein bars + 50ml olive oil (Dietary Supplement)

结局指标

主要结局

Gallbladder Volume

时间窗: during procedure

Formula for Ultrasound Measurement of Gallbladder Volume (L × W × D × 0.52). Measurements were taken every 20 minutes starting from 30 minutes after the intervention, with a total of 5 measurements (i.e., the gallbladder volume was measured at 30 minutes, 50 minutes, 70 minutes, 90 minutes, and 110 minutes respectively).

Gallbladder contraction rate

时间窗: during procedure

Subtract the volume of the gallbladder after intervention from the volume of the gallbladder on an empty stomach, then divide by the volume of the gallbladder on an empty stomach, and finally multiply by A-B/A%. The gallbladder contraction rate was calculated at all the above time points.

次要结局

  • Presence of Abdominal(30 days)
  • Occurrence of Acute Pancreatitis(30 days)
  • Occurrence of Gastrointestinal Bleeding Post-Intervention(30 days)

研究者

发起方
Hepatopancreatobiliary Surgery Institute of Gansu Province
申办方类型
Other
责任方
Principal Investigator
主要研究者

Wenbo Meng

Director of Surgery

Hepatopancreatobiliary Surgery Institute of Gansu Province

研究点 (5)

Loading locations...

相似试验

招募中
2 期
Safety Trial, DSC vs. BAT in SR acute GvHDGraft vs Host Disease
2024-511768-97-01Uppsala University Hospital45
进行中(未招募)
不适用
Multicenter, prospective, randomized, open-label study of the safety and efficacy of a Certican® -based regimen versus a calcineurin inhibitor (CNI)-based regimen in maintenance heart transplant recipients with CNI-related renal insufficiency - CeCaRiThis study is designed to evaluate whether Certican® initiation, together with discontinuation of calcineurin inhibitors (CNIs) will have a beneficial effect on the renal function in maintenance heart transplant recipients with CNI-related renal impairment, while maintaining efficacy.
EUCTR2007-002102-22-BEGasthuisberg Leuven150
进行中(未招募)
1 期
Phase I-II multicenter, randomized, open-label, clinical and pharmacokinetic study of plitidepsin, administered alone or in combination with dacarbazine, as front-line therapy to subjects with unresectable advanced melanoma - Not availableunresectable advanced melanomaMedDRA version: 5.0 Level: LLT Classification code 10027150
EUCTR2005-001161-34-GBPharma Mar SA60
进行中(未招募)
1 期
Phase I-II multicenter, randomized, open-label, clinical and pharmacokinetic study of plitidepsin, administered alone or in combination with dacarbazine, as front-line therapy to subjects with unresectable advanced melanomaunresectable advanced melanomaMedDRA version: 5.0Level: LLTClassification code 10027150
EUCTR2005-001161-34-ESPharma Mar SA, sociedad unipersonal60
进行中(未招募)
不适用
An open-label, randomized, multicenter, parallel-group study to demonstrate correction of anemia using once every four weeks subcutaneous injections of RO0503821 in patients with chronic kidney disease who are not on dialysis - CORDATUSChronic renal anemiaMedDRA version: 8.1Level: LLTClassification code 10058124Term: Nephrogenic anemia
EUCTR2006-001434-41-HUF. Hoffmann-La Roche Ltd300